Targeting the EGFR and immune pathways in squamous cell carcinoma of the head and neck (SCCHN): forging a new alliance

Despite the recent approval of immune-modulatory agents, EGFR inhibition continues to be a cornerstone in the management of SCCHN namely in combination with radiotherapy in the treatment of locoregionally advanced disease as well as in platinum sensitive recurrent or metastatic disease in the first...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Mol Cancer Ther
Hoofdauteurs: Saba, Nabil F, Chen, Zhuo Gerogia, Haigentz, Missak, Bossi, Paolo, Rinaldo, Alessandra, Rodrigo, Juan P, Mäkitie, Antti A., Takes, Robert P, Strojan, Primoz, Vermorken, Jan B, Ferlito, Alfio
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2019
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6830522/
https://ncbi.nlm.nih.gov/pubmed/31676542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-19-0214
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items